509 related articles for article (PubMed ID: 25895531)
1. B cell antigen presentation is sufficient to drive neuroinflammation in an animal model of multiple sclerosis.
Parker Harp CR; Archambault AS; Sim J; Ferris ST; Mikesell RJ; Koni PA; Shimoda M; Linington C; Russell JH; Wu GF
J Immunol; 2015 Jun; 194(11):5077-84. PubMed ID: 25895531
[TBL] [Abstract][Full Text] [Related]
2. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
3. Neuroantigen-specific autoregulatory CD8+ T cells inhibit autoimmune demyelination through modulation of dendritic cell function.
Kashi VP; Ortega SB; Karandikar NJ
PLoS One; 2014; 9(8):e105763. PubMed ID: 25144738
[TBL] [Abstract][Full Text] [Related]
4. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.
Mony JT; Khorooshi R; Owens T
Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747
[TBL] [Abstract][Full Text] [Related]
5. Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen.
Kinzel S; Lehmann-Horn K; Torke S; Häusler D; Winkler A; Stadelmann C; Payne N; Feldmann L; Saiz A; Reindl M; Lalive PH; Bernard CC; Brück W; Weber MS
Acta Neuropathol; 2016 Jul; 132(1):43-58. PubMed ID: 27022743
[TBL] [Abstract][Full Text] [Related]
6. B cells are capable of independently eliciting rapid reactivation of encephalitogenic CD4 T cells in a murine model of multiple sclerosis.
Parker Harp CR; Archambault AS; Sim J; Shlomchik MJ; Russell JH; Wu GF
PLoS One; 2018; 13(6):e0199694. PubMed ID: 29944721
[TBL] [Abstract][Full Text] [Related]
7. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease.
Stüve O; Youssef S; Slavin AJ; King CL; Patarroyo JC; Hirschberg DL; Brickey WJ; Soos JM; Piskurich JF; Chapman HA; Zamvil SS
J Immunol; 2002 Dec; 169(12):6720-32. PubMed ID: 12471103
[TBL] [Abstract][Full Text] [Related]
8. Inconsistence between number and function of autoreactive T cells in the course of experimental autoimmune encephalomyelitis.
Wan X; Pei W; Zhang Y; Zhang L; Shahzad KA; Xu T; Shen C
Immunol Invest; 2018 Jan; 47(1):1-17. PubMed ID: 28872930
[TBL] [Abstract][Full Text] [Related]
9. Limited sufficiency of antigen presentation by dendritic cells in models of central nervous system autoimmunity.
Wu GF; Shindler KS; Allenspach EJ; Stephen TL; Thomas HL; Mikesell RJ; Cross AH; Laufer TM
J Autoimmun; 2011 Feb; 36(1):56-64. PubMed ID: 21095100
[TBL] [Abstract][Full Text] [Related]
10. CYBB/NOX2 in conventional DCs controls T cell encephalitogenicity during neuroinflammation.
Keller CW; Kotur MB; Mundt S; Dokalis N; Ligeon LA; Shah AM; Prinz M; Becher B; Münz C; Lünemann JD
Autophagy; 2021 May; 17(5):1244-1258. PubMed ID: 32401602
[TBL] [Abstract][Full Text] [Related]
11. Redundancy between Cysteine Cathepsins in Murine Experimental Autoimmune Encephalomyelitis.
Allan ER; Yates RM
PLoS One; 2015; 10(6):e0128945. PubMed ID: 26075905
[TBL] [Abstract][Full Text] [Related]
12. Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE.
Isaksson M; Lundgren BA; Ahlgren KM; Kämpe O; Lobell A
Eur J Immunol; 2012 Oct; 42(10):2555-63. PubMed ID: 22806332
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the encephalitogenic immune response in a model of multiple sclerosis.
de Graaf KL; Barth S; Herrmann MM; Storch MK; Wiesmüller KH; Weissert R
Eur J Immunol; 2008 Jan; 38(1):299-308. PubMed ID: 18050272
[TBL] [Abstract][Full Text] [Related]
14. A Tolerogenic Artificial APC Durably Ameliorates Experimental Autoimmune Encephalomyelitis by Directly and Selectively Modulating Myelin Peptide-Autoreactive CD4
Wan X; Pei W; Shahzad KA; Zhang L; Song S; Jin X; Wang L; Zhao C; Shen C
J Immunol; 2018 Aug; 201(4):1194-1210. PubMed ID: 29987163
[TBL] [Abstract][Full Text] [Related]
15. A Spontaneous Model of Experimental Autoimmune Encephalomyelitis Provides Evidence of MOG-Specific B Cell Recruitment and Clonal Expansion.
Salvador F; Deramoudt L; Leprêtre F; Figeac M; Guerrier T; Boucher J; Bas M; Journiac N; Peters A; Mars LT; Zéphir H
Front Immunol; 2022; 13():755900. PubMed ID: 35185870
[TBL] [Abstract][Full Text] [Related]
16. Antigen-oriented T cell migration contributes to myelin peptide induced-EAE and immune tolerance.
Zheng P; Fu H; Wei G; Wei Z; Zhang J; Ma X; Rui D; Meng X; Ming L
Clin Immunol; 2016 Aug; 169():36-46. PubMed ID: 27327113
[TBL] [Abstract][Full Text] [Related]
17. The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
Lee DH; Linker RA
Expert Opin Ther Targets; 2012 May; 16(5):451-62. PubMed ID: 22494461
[TBL] [Abstract][Full Text] [Related]
18. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.
Batoulis H; Addicks K; Kuerten S
Ann Anat; 2010 Aug; 192(4):179-93. PubMed ID: 20692821
[TBL] [Abstract][Full Text] [Related]
19. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis.
Iglesias A; Bauer J; Litzenburger T; Schubart A; Linington C
Glia; 2001 Nov; 36(2):220-34. PubMed ID: 11596130
[TBL] [Abstract][Full Text] [Related]
20. GM-CSF Promotes Chronic Disability in Experimental Autoimmune Encephalomyelitis by Altering the Composition of Central Nervous System-Infiltrating Cells, but Is Dispensable for Disease Induction.
Duncker PC; Stoolman JS; Huber AK; Segal BM
J Immunol; 2018 Feb; 200(3):966-973. PubMed ID: 29288202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
